| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $106.5M | +350.9% |
| R&D Expense | $12.7M | -69.7% |
| SG&A Expense | $77.6M | +41.5% |
| Operating Income | -$62.9M | +27.7% |
| Pre-tax Income | $86.7M | +196.2% |
| Income Tax | $3.4M | -77.6% |
| Net Income | $83.2M | +178.9% |
| EPS (Basic) | $1.40 | +161.4% |
| EPS (Diluted) | $1.35 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $62.4M | +84.7% |
| Accounts Receivable | $23.3M | +128.6% |
| Inventory | $1.7M | -11.7% |
| Current Assets | $223.0M | +159.2% |
| Total Assets | $284.7M | +59.8% |
| Current Liabilities | $39.3M | +15.3% |
| Long-term Debt | $61.9M | +4.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.6M | +97.7% |
| Capital Expenditures | $835K | — |
| Investing Cash Flow | $18.1M | +181.8% |
| Financing Cash Flow | $12.1M | -85.3% |
| Free Cash Flow | -$2.4M | +96.5% |
| +159.2% |
| Total Liabilities |
| $130.1M |
| -6.1% |
| Stockholders' Equity | $154.7M | +289.9% |